These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6195458)

  • 1. Humoral and renal effects of MK-421 (enalapril) in hypertensive subjects.
    de Leeuw PW; Hoogma RP; van Soest GA; Tchang PT; Birkenhäger WH
    J Cardiovasc Pharmacol; 1983; 5(5):731-6. PubMed ID: 6195458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the pathophysiologic profile of blood pressure determinants during short-term enalapril administration.
    de Leeuw PW; Birkenhäger WH
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S26-9. PubMed ID: 2422490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiological effects of short-term treatment with enalapril in hypertensive patients.
    de Leeuw PW; Hoogma RP; van Soest GA; van Es PN; Birkenhäger WH
    J Hypertens Suppl; 1983 Oct; 1(1):87-91. PubMed ID: 6100612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enalapril in treatment of hypertension with renal artery stenosis. Changes in blood pressure, renin, angiotensin I and II, renal function, and body composition.
    Hodsman GP; Brown JJ; Cumming AM; Davies DL; East BW; Lever AF; Morton JJ; Murray GD; Robertson JI
    Am J Med; 1984 Aug; 77(2A):52-60. PubMed ID: 6089557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the new oral angiotensin converting enzyme inhibitor MK-421 in human hypertension.
    Gavras H; Biollaz J; Waeber B; Brunner HR; Gavras I; Davies RO
    Clin Exp Hypertens A; 1982; 4(1-2):303-14. PubMed ID: 6280900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natriuretic effect and changes in renal haemodynamics induced by enalapril in essential hypertension.
    Sánchez RA; Marcó E; Gilbert HB; Raffaele P; Brito M; Giménez M; Moledo LI
    Drugs; 1985; 30 Suppl 1():49-58. PubMed ID: 2994987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic and antihypertensive effects of the new oral angiotensin-converting-enzyme inhibitor MK-421 (enalapril).
    Fouad FM; Tarazi RC; Bravo EL; Textor SC
    Hypertension; 1984; 6(2 Pt 1):167-74. PubMed ID: 6327515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive effect of the new oral angiotensin converting enzyme inhibitor "MK-421".
    Gavras H; Biollaz J; Waeber B; Brunner HR; Gavras I; Davies RO
    Lancet; 1981 Sep; 2(8246):543-7. PubMed ID: 6116000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives.
    Redgrave J; Rabinowe S; Hollenberg NK; Williams GH
    J Clin Invest; 1985 Apr; 75(4):1285-90. PubMed ID: 2985655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of enalapril (MK-421), an orally active angiotensin I converting enzyme inhibitor, on blood pressure, active and inactive plasma renin, urinary prostaglandin E2, and kallikrein excretion in conscious rats.
    Schiffrin EL; Gutkowska J; Thibault G; Genest J
    Can J Physiol Pharmacol; 1984 Jan; 62(1):116-23. PubMed ID: 6143602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade.
    Biollaz J; Brunner HR; Gavras I; Waeber B; Gavras H
    J Cardiovasc Pharmacol; 1982; 4(6):966-72. PubMed ID: 6185790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of enalapril in patients with congestive heart failure and patients with hypertension.
    Schwartz JB; Taylor A; Abernethy D; O'Meara M; Farmer J; Young J; Nelson E; Pool J; Mitchell JR
    J Cardiovasc Pharmacol; 1985; 7(4):767-76. PubMed ID: 2410720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enalapril in the treatment of hypertension with renal artery stenosis.
    Hodsman GP; Brown JJ; Cumming AM; Davies DL; East BW; Lever AF; Morton JJ; Murray GD; Robertson I; Robertson JI
    Br Med J (Clin Res Ed); 1983 Nov; 287(6403):1413-7. PubMed ID: 6315126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dietary sodium on angiotensin-converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril (MK-421) in essential hypertension.
    Jackson B; Cubela R; Johnston CI
    J Hypertens; 1984 Aug; 2(4):371-7. PubMed ID: 6099390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the oral angiotensin-converting enzyme inhibitor MK-421 in human hypertension.
    Gavras H; Biollaz J; Waeber B; Brunner HR; Gavras I; Sackel H; Charocopos F; Davies RO
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():281s-283s. PubMed ID: 6274572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril.
    Nussberger J; Wuerzner G; Jensen C; Brunner HR
    Hypertension; 2002 Jan; 39(1):E1-8. PubMed ID: 11799102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative studies: enalapril versus hydrochlorothiazide as first-step therapy for the treatment of primary hypertension.
    Bauer JH; Jones LB
    Am J Kidney Dis; 1984 Jul; 4(1):55-62. PubMed ID: 6331157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The acute effects of the new angiotensin I-converting enzyme inhibitor, enalapril maleate, on blood pressure, plasma renin, aldosterone and kinins in hypertensive patients].
    Gotoh M; Mizuno K; Hashimoto S; Kunii N; Fukuchi S
    Nihon Naibunpi Gakkai Zasshi; 1985 May; 61(5):619-29. PubMed ID: 2991035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report.
    Karlberg BE; Fyhrquist F; Grönhagen-Riska C; Tikkanen I; Ohman KP
    Scand J Urol Nephrol Suppl; 1984; 79():103-6. PubMed ID: 6089307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of enalapril, a new converting enzyme inhibitor, in hypertension.
    Ferguson RK; Vlasses PH; Swanson BN; Mojaverian P; Hichens M; Irvin JD; Huber PB
    Clin Pharmacol Ther; 1982 Jul; 32(1):48-53. PubMed ID: 6282527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.